Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00790270 · ClinicalTrials.gov registry record · Phase 2

Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial

A Phase 2 study, sponsored by Stony Brook University.

Completed
Registry status
Phase 2
Development phase
61
Enrollment target

NCT00790270: Completed Phase 2 study, sponsored by Stony Brook University.

NCT00790270 is a Phase 2 study that has completed, run by Stony Brook University. The registered enrollment target is 61 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00790270, a Phase 2 study, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
Phase 2
Development phase
61 participants
Enrollment target

Study Summary

The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone.

Interventions

  • DRUG Ibuprofen
  • DRUG Cyclobenzaprine
  • DRUG Ibuprofen plus Cyclobenzaprine

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2003-01
Est. Completion 2004-01
Phase Phase 2
Stony Brook University

127 total trials

What the finished NCT00790270 record still lists

NCT00790270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (54% lower).

The record links to 0 conditions, and to 3 interventions - of which Ibuprofen is the first listed.

NCT00790270 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00790270 about?

NCT00790270 is a clinical study titled "Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial". The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone.

What is the current status of trial NCT00790270?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2003-01. Estimated completion is 2004-01.

What interventions are being tested in trial NCT00790270?

The interventions under investigation include: Ibuprofen (DRUG), Cyclobenzaprine (DRUG), Ibuprofen plus Cyclobenzaprine (DRUG).

Who is sponsoring clinical trial NCT00790270?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00790270's enrollment target sits among peer trials

61 1026th of 2000 higher than 974 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00790270, the US trial registry maintained by the National Library of Medicine. NCT00790270 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.